|
William Beasley is Director, Clinical Affairs. He previously served five years in clinical trials management at Covance, Inc., a large, multinational Clinical Research Organization (CRO) where he directed phase I - phase III clinical trials for major international pharmaceutical companies. In his current position, Mr. Beasley successfully conducted the pivotal trial on GEM 21S. He has implemented an electronic data capture (EDC) instrument developed by a small CRO into the company's clinical program, substantially improving clinical trial efficiencies. Mr. Beasley's clinical research management experience includes a diverse range of pharmaceuticals, biologics, medical devices and combination products in multiple therapy areas. | 